Honokiol: Treatment for malignant peripheral nerve sheath tumors
Author:
- 6 July 2022
- journal article
- letter
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 19 (5) , 1485-1486
Abstract
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic SocietyKeywords
This publication has 13 references indexed in Scilit:
- Plexiform NeurofibromaMedicine, 2016
- Honokiol induces autophagy of neuroblastoma cells through activating the PI3K/Akt/mTOR and endoplasmic reticular stress/ERK1/2 signaling pathways and suppressing cell migrationCancer Letters, 2016
- Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathwayThe American Journal of Surgery, 2014
- Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular dockingPhytomedicine, 2014
- Eyes on the Prize: Limbal Stem Cells and Corneal RestorationCell Stem Cell, 2014
- Malignant Peripheral Nerve Sheath TumorsThe Oncologist, 2014
- Development of an international internet-based neurofibromatosis Type 1 Patient registryContemporary Clinical Trials, 2013
- Therapeutic applications of compounds in the Magnolia familyPharmacology & Therapeutics, 2011
- Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancerEuropean Journal of Pharmacology, 2008
- Regulation of Progenitor Cell Fusion by ABCB5 P-glycoprotein, a Novel Human ATP-binding Cassette TransporterJournal of Biological Chemistry, 2003